צמיחת רווח נקי למניה משנה לשנה ב-12 החודשים האחרונים Catheter Precision Inc (VTAK)

Catheter Precision is implementing energy-efficient electronics and safe materials to combat arrhythmia. The quarterly earnings per share trend confirms this trajectory, where 86.60 serves as the base parameter value. Revenues are based on the sale of disposable catheters that offset the cost of the equipment. However, the early stage of commercialization and physician training costs are temporarily limiting the company's operating leverage.

This indicator serves as a key filter during asset stress testing, enabling the identification of hidden profitability degradation prior to the publication of official reports. The metric measures the percentage deviation of net income per share from the previous quarter, while the quarterly EPS trend for Catheter Precision (VTAK) reflects the monetization efficiency of consumables within established clinical protocols for arrhythmia treatment.